Oxford Science Enterprises is an independent billion-pound investment company created in 2015 through its unique partnership with the University of Oxford. The fund manages a core portfolio of ~40 companies spanning life sciences, health tech, and deep tech, with 11 Seed-stage and 29 Series A investments.
Auto-extracted from press releases.
Auto-detected from Oxford Science Enterprises's website.
Focus and check size from the firm's website. Website reachable as of Aug 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.